Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma

被引:5
|
作者
Chan, Stephen L. [1 ]
Hui, Edwin P. [1 ]
Leung, Sing F. [1 ]
Chan, Anthony T. C. [1 ]
Ma, Brigette B. Y. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1186/1471-2407-6-259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating plasma Epstein Barr Virus DNA (EBV-DNA) is a sensitive and specific marker of nasopharyngeal carcinoma (NPC). The mainstay of treatment of metastatic NPC is systemic chemotherapy and resection for solitary metastasis. Despite high response rate to chemotherapy, complete remission is uncommonly seen. Case Presentation: We report a case of recurrent metastatic NPC in a 43-year-old man, who achieved complete remission three times with chemotherapy and surgery. Serial plasma EBV-DNA levels were measured during the course of disease. The patient had three episodes of recurrences of NPC manifested as distant metastasis. Both time, rise in the plasma EBV-DNA level preceded detection of recurrences by imaging. Following systemic chemotherapy, he achieved complete remission each time, of which was confirmed by 18-flourodeoxyglucose positron emission tomography and hepatectomy pathology. The plasma EBV-DNA level dropped to zero copy/ml at the time of each remission. Conclusion: This case highlights the high chemosensitivity of NPC by illustrating a rare occurrence of complete response of metastatic NPC to chemotherapy. This case also underscores the usefulness of EBV-DNA as a useful tool in monitoring NPC by its ability to detect early recurrence and excellent correlation with treatment response.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
    Huang, Luo
    Sim, Adelene Y. L.
    Wu, Yongzhong
    Liang, Zhongguo
    Li, Kaiguo
    Du, Youqin
    Ong, Enya H. W.
    Tan, Hong Qi
    Wee, Joseph T. S.
    Xie, Yue
    Shu, Xiaolei
    Wang, Ying
    Chua, Melvin L. K.
    Zhu, Xiaodong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [42] CARCINOMA IN RECURRENT NASOPHARYNGEAL FIBROMA
    SHARMA, U
    GUPTA, PK
    SANYAL, B
    KASLIWAL, KS
    BRITISH JOURNAL OF RADIOLOGY, 1968, 41 (488): : 625 - &
  • [43] RETREATMENT OF RECURRENT NASOPHARYNGEAL CARCINOMA
    MCNEESE, MD
    FLETCHER, GH
    RADIOLOGY, 1981, 138 (01) : 191 - 193
  • [44] Treatment for metastatic nasopharyngeal carcinoma
    Bensouda, Y.
    Kaikani, W.
    Ahbeddou, N.
    Rahhali, R.
    Jabri, M.
    Mrabti, H.
    Boussen, H.
    Errihani, H.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2011, 128 (02) : 79 - 85
  • [45] MRI in recurrent nasopharyngeal carcinoma
    Ng, SH
    Chang, JTC
    Ko, SF
    Wan, YL
    Tang, LM
    Chen, WC
    NEURORADIOLOGY, 1999, 41 (11) : 855 - 862
  • [46] Surgery for recurrent nasopharyngeal carcinoma
    Wei, WI
    Yuen, PW
    Lam, LK
    Ho, WK
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 15 - 19
  • [47] MRI in recurrent nasopharyngeal carcinoma
    S. H. Ng
    J. T. C. Chang
    S. F. Ko
    Y. L. Wan
    L. M. Tang
    W. C. Chen
    Neuroradiology, 1999, 41 : 855 - 862
  • [48] Locally recurrent nasopharyngeal carcinoma
    Chang, JTC
    See, LC
    Liao, CT
    Ng, SH
    Wang, CH
    Chen, IH
    Tsang, NM
    Tseng, CK
    Tang, SG
    Hong, JH
    RADIOTHERAPY AND ONCOLOGY, 2000, 54 (02) : 135 - 142
  • [49] Nasopharyngeal Carcinoma Metastatic to the Mandible
    Huang, Po Hsien
    Shyng, Yih Chuen
    Sloan, P.
    Ou, Keng-Liang
    Hsia, Y. J.
    Devlin, H.
    OPEN DENTISTRY JOURNAL, 2010, 4 : 195 - 197
  • [50] Establishing M1 stage subdivisions by incorporating radiological features and Epstein-Barr virus DNA for metastatic nasopharyngeal carcinoma
    Zheng, Wei-Hong
    He, Xiao-Jun
    Chen, Fo-Ping
    Lin, Li
    Huang, Xiao-Dan
    Zhou, Hua-Qiang
    Kou, Jia
    Lv, Jia-Wei
    Ma, Jun
    Zhou, Guan-Qun
    Sun, Ying
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (04)